Concepedia

Moritz Widmaier

MW

Statistics

Publications

9

Citations

1.2K

H-Index

9

Active since

2008

Affiliations

Max Planck Institute of Biochemistry(Current)

AstraZeneca (United States)

Moritz Widmaier is an author at Max Planck Institute of Biochemistry specializing in medicine, pathology, and cell signaling.

Top concepts

Publications per year

2008–2019

9

Publications

9

Kindlin-2 cooperates with talin to activate integrins and induces cell spreading by directly binding paxillin

Marina Theodosiou, Moritz Widmaier, Ralph T. Böttcher et al. · eLife · 2016 · 266 citations · Full text

, , +14

Loss of Kindlin-1 Causes Skin Atrophy and Lethal Neonatal Intestinal Epithelial Dysfunction

Siegfried Ussar, Markus Moser, Moritz Widmaier et al. · PLoS Genetics · 2008 · 208 citations · Full text

, , +12

Sorting nexin 17 prevents lysosomal degradation of β1 integrins by binding to the β1-integrin tail

Ralph T. Böttcher, Christopher Stremmel, Alexander Meves et al. · Nature Cell Biology · 2012 · 205 citations

, , +11

Kindlin-1 controls Wnt and TGF-β availability to regulate cutaneous stem cell proliferation

Emanuel Rognoni, Moritz Widmaier, Madis Jakobson et al. · Nature Medicine · 2014 · 143 citations · Full text

, , +11

Automated image analysis of NSCLC biopsies to predict response to anti-PD-L1 therapy

Sonja Althammer, Tze Heng Tan, Andreas Spitzmüller et al. · Journal for ImmunoTherapy of Cancer · 2019 · 103 citations · Full text

1–5 of 9